Cargando…
Application of cell-free DNA for genomic tumor profiling: a feasibility study
PURPOSE: Access to genomic tumor material is required to select patients for targeted therapies. However, tissue biopsies are not always feasible and therefore circulating cell-free DNA (cfDNA) has emerged as an alternative. Here we investigate the utility of cfDNA for genomic tumor profiling in the...
Autores principales: | Ahlborn, Lise B., Rohrberg, Kristoffer S., Gabrielaite, Migle, Tuxen, Ida V., Yde, Christina W., Spanggaard, Iben, Santoni-Rugiu, Eric, Nielsen, Finn C., Lassen, Ulrik, Mau-Sorensen, Morten, Østrup, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402712/ https://www.ncbi.nlm.nih.gov/pubmed/30858924 http://dx.doi.org/10.18632/oncotarget.26642 |
Ejemplares similares
-
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
por: Bertelsen, Birgitte, et al.
Publicado: (2019) -
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
por: Ahlborn, Lise Barlebo, et al.
Publicado: (2018) -
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
por: Viller Tuxen, Ida, et al.
Publicado: (2019) -
Detection of copy number alterations in cell-free tumor DNA from plasma
por: Østrup, Olga, et al.
Publicado: (2017) -
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
por: Araujo B. de Lima, Vinicius, et al.
Publicado: (2021)